Mimetogen Pharmaceuticals Inc. (“Mimetogen”) today announced positive top line data from a Phase II clinical trial with MIM-D3, its lead drug for the treatment of dry eye. The trial demonstrated statistically significant improvements in signs and sympt…
Month: June 2011
ADA: Anti-VEGF ‘Impressive’ In Sharpening Vision
The good news continues to roll in for ranibizumab (Lucentis) in diabetic macular edema with positive results from the RIDE and RISE trials.
ADA: Anti-VEGF ‘Impressive’ in Sharpening Vision (CME/CE, with video)
SAN DIEGO (MedPage Today) — The good news continues to roll in for ranibizumab (Lucentis) in diabetic macular edema with positive RIDE and RISE trial results.
Mimetogen Pharmaceuticals Inc. Announces Positive Top Line Data From Phase II Clinical Trial Of MIM-D3 For Dry Eye Disease
Mimetogen Pharmaceuticals Inc. (“Mimetogen”) today announced positive top line data from a Phase II clinical trial with MIM-D3, its lead drug for the treatment of dry eye. The trial demonstrated statistically significant improvements in signs and sympt…
Understanding Zoster: Impact on the Individual and on Society
From chickenpox to shingles, the journey and unfortunate destination of varicella.
Reichert Technologies Launches New Advantage Plus Chair And Stand
Reichert Technologies is pleased to announce the release of their new Advantage Plus Chair and Stand. The Advantage Plus unit features the same robust construction as the original Advantage Chair and Stand, which has successfully served the eye care co…
The Revolutionary Training Tool For Cataract Surgery
The Kitaro DryLab and WetLab Kits are revolutionary educational and training tools for cataract surgery. These innovative kits offer realistic surgical simulation through specially designed synthetic materials that give the look and feel of the natural…
EYLEAT (aflibercept Injection) Submitted In Japan For Marketing Authorization For The Treatment Of Wet Age-Related Macular Degeneration
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced thatBayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEAT, also known as …
BCVA Stabilizes With As-Needed Anti-VEGF
A low number of anti-VEGF injections in patients with neovascular age-related macular degeneration produced positive results after 1 year of treatment, but the results fell short of the efficacy associated with more frequent injections, according to a …
Study Links Celiac Disease to Cataract Risk
People with celiac disease may have a slightly increased risk of cataracts, a new study suggests. Reuters Health Information
A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications
Source: Eye
Area: Evidence > Medicines Management > References
Purpose: To learn from patient safety incidents (PSIs) following recent introduction of vascular endothelial growth factor inhibitor medications (anti-VEGF) in ophthalmic care, as reported…
CHMP does not recommend approval of voclosporin (Luveniq®) for chronic non-infectious uveitis
Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion, recommending that a marketing authorisation should not be granted for the orphan medicine voclosporin (Luveniq®), …
Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML
Over a decade ago, Canadian patients diagnosed with chronic myeloid leukemia (CML), celebrated when PrGleevec (imatinib mesylate) was approved in Canada.
STAAR Surgical completes first procedures to implant Visian ICL V4c design
STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive refractive lenses that go inside the eye, today announced the completion of the first procedures to implant its recently CE Mark-approved Visian Implantable …
ACT Granted EU Orphan Medicinal Product Designation For HESC-Derived RPE Cells For Treatment Of Stargardt’s Disease
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today that the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has officially granted ACT’s human embryonic stem cell (hESC)-der…
Minimally Invasive Facial Rejuvenation: A Case-Based Discussion
Drs. Marc Cohen, Steven Dayan, and Thomas Rohrer present and discuss cases that illustrate the use of minimally invasive techniques for facial rejuvenation.
STAAR Surgical Announces First Visian® ICL V4c Implants In Europe
STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive refractive lenses that go inside the eye, today announced the completion of the first procedures to implant its recently CE Mark-approved Visian® Implantabl…
Suprachoroidal Tube Drainage May Be Effective As Initial Glaucoma Treatment
Suprachoroidal tube drainage of aqueous humor may be a preferred initial treatment for glaucoma patients without prior trabeculectomy, a study found.
NEW! The Revolutionary Training Tool For Cataract Surgery
The Kitaro DryLab and WetLab Kits are revolutionary educational and training tools for cataract surgery. These innovative kits offer realistic surgical simulation through specially designed synthetic materials that give the look and feel of the natural…
Physicist’s Discovery Alters Conventional Understanding Of Sight
A discovery by a team of researchers led by a Syracuse University physicist sheds new light on how the vision process is initiated. For almost 50 years, scientists have believed that light signals could not be initiated unless special light-receptor mo…